Osaic Holdings
LTRN icon

Osaic Holdings’s Lantern Pharma LTRN Stock Holding History

Osaic Holdings’s Portfolio LTRN Stock Details LTRN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$301 Buy
220
+5
+2% +$14 ﹤0.01% 7512
2025
Q4 		$651 Hold
215
– – ﹤0.01% 7393
2025
Q3 		$935 Hold
215
– – ﹤0.01% 7380
2025
Q2 		$679 Buy
215
+115
+115% +$388 ﹤0.01% 7280
2025
Q1 		$354 Buy
+100
New +$415 ﹤0.01% 7072
2024
Q2 		– Sell
-410
Closed -$3.61K – 7530
2024
Q1 		$3.61K Buy
410
+210
+105% +$1.12K ﹤0.01% 6231
2023
Q4 		$856 Hold
200
– – ﹤0.01% 6800
2023
Q3 		$682 Hold
200
– – ﹤0.01% 6926
2023
Q2 		$1.13K Buy
+200
New +$1.03K ﹤0.01% 6848
2023
Q1 		– Sell
-864
Closed -$5K – 7546
2022
Q4 		$5K Hold
864
– – ﹤0.01% 6285
2022
Q3 		$4K Sell
864
-2,496
-74% -$13.4K ﹤0.01% 6489
2022
Q2 		$19K Buy
3,360
+285
+9% +$1.7K ﹤0.01% 5653
2022
Q1 		$22K Sell
3,075
-2,256
-42% -$15.1K ﹤0.01% 5628
2021
Q4 		$43K Buy
5,331
+2,561
+92% +$23.4K ﹤0.01% 5253
2021
Q3 		$31K Buy
2,770
+1,770
+177% +$22.9K ﹤0.01% 5461
2021
Q2 		$15K Sell
1,000
-300
-23% -$4.63K ﹤0.01% 5828
2021
Q1 		$24K Buy
+1,300
New +$22.8K ﹤0.01% 5363

Other funds holding LTRN

BCM
BIOS Capital Management Fort Worth, Texas $52.9M AUM 30.51% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
CM
CM Management Gulf Breeze, Florida $120M AUM 37.12% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
WIM
Westside Investment Management Santa Monica, California $761M AUM 39.85% 1-Year Est. Return
VC
Voss Capital Houston, Texas $1.88B AUM 1.03% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Osaic Holdings's LTRN Position: Q1 2026 in Review

Osaic Holdings increased its Lantern Pharma (LTRN) stake by 2.3% in Q1 2026, buying an estimated $14 and bringing the position to 220 shares worth $301. The position accounts for ﹤0.01% of the portfolio, ranked #7512.

Osaic Holdings first reported a position in LTRN in Q1 2021 and has held it in 17 quarters since. The position peaked at $43K in Q4 2021. 33 funds tracked by Wall St. Rank hold LTRN as of Q1 2026.

  • Osaic Holdings held 220 shares of Lantern Pharma worth $301 as of Q1 2026.
  • Osaic Holdings bought 5 Lantern Pharma shares in Q1 2026, an estimated $14.
  • Lantern Pharma made up ﹤0.01% of Osaic Holdings's portfolio in Q1 2026, its #7512 holding.
  • Osaic Holdings first reported a position in Lantern Pharma in Q1 2021 and has held it in 17 quarters since.
  • Osaic Holdings's Lantern Pharma position peaked at $43K in Q4 2021.
  • 33 funds tracked by Wall St. Rank held Lantern Pharma as of Q1 2026.

Based on Osaic Holdings's 13F filing for Q1 2026, filed 15 May 2026.